OOIR: Observatory of International Research

Papers

(The H4-Index of ERJ Open Research is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI)versusintercalated TKI with chemotherapy forEGFR-mutated nonsmall cell lung cancer	142
ERS International Congress 2021: highlights from the Epidemiology and Environment Assembly	102
An observational study ofPseudomonas aeruginosain adult long-term ventilation	80
Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis	75
Exertional inspiratory capacity and operating lung volumes in health: a population-based study	55
Pseudomonas aeruginosainfection is linked to increases in cardiovascular events post exacerbation in bronchiectasis	54
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry	50
Coughing during spirometry is not uncommon in healthy middle-aged and elderly subjects	46
Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea	45
Uncontrolled asthma from childhood to young adulthood associates with airflow obstruction	44
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care	44
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients	39
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)	38
Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis	38
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough	37
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience	37
Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study	36
Pulmonary rehabilitation in long COVID: more than just natural recovery!?	36
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma	35
Influence of sex, season and environmental air quality on experimental human pneumococcal carriage acquisition: a retrospective cohort analysis	35
Pulmonary disease as a risk factor for transfusion-related acute lung injury	34
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset	32
Defining end-systolic pressure for single-beat estimation of right ventricle–pulmonary artery coupling: simple… but not really	31
“Lung diffusing capacity for nitric oxide measured by two commercial devices: a randomised crossover comparison in healthy adults”. Thomas Radtke, Quintin de Groot, Sarah R. Haile, Marion Maggi, Conni	31
Predictors of outcome of chest tube drainage of nonpurulent exudative pleural effusions	30

Blood eosinophils as a predictor of treatment response in adults with difficult-to-treat chronic cough	29
Aerosol particle concentrations with different oxygen devices and interfaces for spontaneous breathing patients with tracheostomy: a randomised crossover trial	29
Individual trajectory-based care for COPD: getting closer, but not there yet	28